{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:26:38Z","timestamp":1753892798020,"version":"3.41.2"},"reference-count":63,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Patients with psychosis can develop sexual dysfunction, which may be related to the disease itself, psychosocial factors, somatic comorbidities, and the use of psychotropic medication.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective<\/jats:title><jats:p>We aimed to investigate the type and frequency of sexual dysfunction in patients diagnosed with schizophrenia or bipolar disorder in order to assess the side effects of antipsychotics in sexual function.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This is a multicenter, cross-sectional study, involving patients diagnosed with schizophrenia (79.3%) or bipolar disorder (20.7%) treated in the Department of Psychiatry and Community Mental Health Centers from November 2018 to December 2019. Patients were enrolled in the study after signed informed consent. Demographic and clinical data were collected from patients through a semi-structured interview. The Antipsychotics and Sexual Functioning Questionnaire (ASFQ) was administered to assess sexual function.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 87 outpatients on antipsychotics were recruited in the study. The mean age was 43.6\u2009years, while the mean duration of the disease was 16.9\u2009years. Overall, only 9.1% of patients spontaneously reported sexual dysfunction. Patients treated with oral first-generation antipsychotics had more difficulties in achieving orgasm and decreased erection capacity. In contrast, patients treated with oral second-generation antipsychotics had decreased ejaculation capacity. Patients on antipsychotic combination therapy were associated with higher rates of sexual anhedonia.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>These results suggest that sexual dysfunction is a side effect of antipsychotic treatment, which was spontaneously rarely reported by patients. It seems essential to obtain a psychosexual clinical history before initiating antipsychotic treatment to evaluate following changes and adopt an individualized strategy to manage sexual dysfunction induced by antipsychotics.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fpsyt.2023.1227218","type":"journal-article","created":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T07:13:47Z","timestamp":1693552427000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Frequency of sexual dysfunction in outpatients with severe mental illness in Greece"],"prefix":"10.3389","volume":"14","author":[{"given":"Maria","family":"Angelaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eirini","family":"Alexiou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Artemis","family":"Igoumenou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giorgos","family":"Alevizopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,9,1]]},"reference":[{"year":"2020","key":"ref1"},{"key":"ref2","first-page":"137","article-title":"Sexual dysfunction in male schizophrenic patients","volume":"56","author":"Aizenberg","year":"1995","journal-title":"J Clin Psychiatry"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.pnpbp.2009.11.022","article-title":"Sexual dysfunction in Japanese patients with schizophrenia treated with antipsychotics","volume":"34","author":"Fujii","year":"2010","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1097\/JCP.0b013e3182199bcc","article-title":"Sexual dysfunction in first-episode schizophrenia patients: results from European First Episode Schizophrenia Trial","volume":"31","author":"Malik","year":"2011","journal-title":"J Clin Psychopharmacol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1192\/bjp.bp.111.101220","article-title":"Sexual dysfunction in people with prodromal or first-episode psychosis","volume":"201","author":"Marques","year":"2012","journal-title":"Br J Psychiatry J Ment Sci"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/wps.20509","article-title":"The impact of severe mental disorders and psychotropic medications on sexual health and its implications for clinical management","volume":"17","author":"Montejo","year":"2018","journal-title":"World Psychiatry"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"466","DOI":"10.5173\/ceju.2013.04.art22","article-title":"Psychotropics and sexual dysfunction","volume":"66","author":"Bella","year":"2014","journal-title":"Cent Eur J Urol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1093\/oxfordjournals.schbul.a007130","article-title":"Sexuality and schizophrenia: a review","volume":"30","author":"Kelly","year":"2004","journal-title":"Schizophr Bull"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1097\/YCO.0b013e328017f6c4","article-title":"Sexual dysfunction in schizophrenia","volume":"20","author":"Malik","year":"2007","journal-title":"Curr Opin Psychiatry"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1002\/hup.924","article-title":"Sexual dysfunction in schizophrenia: focus on recent evidence","volume":"23","author":"Baggaley","year":"2008","journal-title":"Hum Psychopharmacol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1080\/09638237.2019.1581333","article-title":"Sexual dysfunction in patients with schizophrenia and schizoaffective disorder and its association with adherence to antipsychotic medication","volume":"29","author":"Souaiby","year":"2020","journal-title":"J Ment Health Abingdon Engl"},{"key":"ref12","first-page":"596898","article-title":"Second generation antipsychotics improve sexual dysfunction in schizophrenia: a randomised controlled trial","volume":"2011","author":"Mahmoud","year":"2011","journal-title":"Schizophr Res Treat"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1055\/s-0033-1347177","article-title":"Sexual dysfunction related to psychotropic drugs: a critical review part II: antipsychotics","volume":"46","author":"La Torre","year":"2013","journal-title":"Pharmacopsychiatry"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1093\/schbul\/sbv001","article-title":"The facts about sexual (Dys) function in schizophrenia: an overview of clinically relevant findings","volume":"41","author":"de Boer","year":"2015","journal-title":"Schizophr Bull"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1097\/YIC.0b013e328341e434","article-title":"A meta-analysis of sexual dysfunction in psychiatric patients taking antipsychotics","volume":"26","author":"Serretti","year":"2011","journal-title":"Int Clin Psychopharmacol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1600-0447.1987.tb10566.x","article-title":"The UKU side effect rating scale. A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients","volume":"334","author":"Lingjaerde","year":"1987","journal-title":"Acta Psychiatr Scand Suppl"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1176\/ps.41.11.1238","article-title":"Sexual side effects of antipsychotic medication: evaluation and interventions","volume":"41","author":"Sullivan","year":"1990","journal-title":"Hosp Community Psychiatry"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1017\/S1461145704005012","article-title":"Prevalence of sexual dysfunction in patients with schizophrenia: international variation and underestimation","volume":"8","author":"Dossenbach","year":"2005","journal-title":"Int J Neuropsychopharmacol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/j.psyneuen.2008.02.008","article-title":"Are sexual side effects of prolactin-raising antipsychotics reducible to serum prolactin?","volume":"33","author":"Knegtering","year":"2008","journal-title":"Psychoneuroendocrinology"},{"key":"ref20","first-page":"181","volume-title":"Antipsychotic Treatment and Sexual Functioning: Role of Prolactin. S.N.","author":"Knegtering","year":"2003"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.eurpsy.2004.06.031","article-title":"Impact of present and past antipsychotic side effects on attitude toward typical antipsychotic treatment and adherence","volume":"19","author":"Lambert","year":"2004","journal-title":"Eur Psychiatry J Assoc Eur Psychiatr."},{"key":"ref22","doi-asserted-by":"publisher","first-page":"3404","DOI":"10.1111\/j.1743-6109.2010.01709.x","article-title":"Frequency of sexual dysfunction in patients with a psychotic disorder receiving antipsychotics","volume":"7","author":"Montejo","year":"2010","journal-title":"J Sex Med"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1017\/S0033291700036539","article-title":"Subjective utility ratings of neuroleptics in treating schizophrenia","volume":"20","author":"Finn","year":"1990","journal-title":"Psychol Med"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"911","DOI":"10.2165\/00023210-200721110-00004","article-title":"Adverse effects of atypical antipsychotics: differential risk and clinical implications","volume":"21","author":"Haddad","year":"2007","journal-title":"CNS Drugs"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"100334","DOI":"10.1016\/j.esxm.2021.100334","article-title":"Translation and Validation of the Greek Version of the Antipsychotics and Sexual Functioning Questionnaire (ASFQ)","volume":"9","author":"Angelaki","year":"2021","journal-title":"Sex Med"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.schres.2013.08.037","article-title":"The Antipsychotics and Sexual Functioning Questionnaire (ASFQ): preliminary evidence for reliability and validity","volume":"150","author":"de Boer","year":"2013","journal-title":"Schizophr Res"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1097\/01.yic.0000185023.55903.ba","article-title":"Evaluation of the subjects\u2019 response to antipsychotics questionnaire","volume":"21","author":"Wolters","year":"2006","journal-title":"Int Clin Psychopharmacol"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.schres.2013.02.027","article-title":"A brief version of the Subjects\u2019 Response to Antipsychotics questionnaire to evaluate treatment effects","volume":"147","author":"Lako","year":"2013","journal-title":"Schizophr Res"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1097\/01.jcp.0000106220.36344.04","article-title":"A randomized open-label study of the impact of quetiapine versus risperidone on sexual functioning","volume":"24","author":"Knegtering","year":"2004","journal-title":"J Clin Psychopharmacol"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1080\/00926230600666378","article-title":"A randomized open-label comparison of the impact of olanzapine versus risperidone on sexual functioning","volume":"32","author":"Knegtering","year":"2006","journal-title":"J Sex Marital Ther"},{"key":"ref31","first-page":"217","article-title":"Sexual dysfunction factors in patients with schizophrenia treated with second generation antipsychotics: not only prolactin","volume":"46","author":"Mart\u00edn","year":"2018","journal-title":"Actas Esp Psiquiatr"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"842","DOI":"10.3389\/fpsyt.2019.00842","article-title":"Attitudes of Italian Psychiatrists Toward the Evaluation of Physical Comorbidities and Sexual Dysfunction in Patients With Schizophrenia","volume":"10","author":"Monteleone","year":"2019","journal-title":"Implic Clin Pract Front Psychiatry"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1708\/2098.22686","article-title":"Predictors of poor adherence to treatment in inpatients with bipolar and psychotic spectrum disorders","volume":"50","author":"Niolu","year":"2015","journal-title":"Riv Psichiatr"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1080\/713847170","article-title":"Frequency of sexual dysfunction and other reproductive side-effects in patients with schizophrenia treated with risperidone, olanzapine, quetiapine, or haloperidol: the results of the EIRE study","volume":"29","author":"Bobes","year":"2003","journal-title":"J Sex Marital Ther"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1192\/bjp.182.1.50","article-title":"Nithsdale schizophrenia surveys 24: sexual dysfunction. Case-control study","volume":"182","author":"Macdonald","year":"2003","journal-title":"Br J Psychiatry"},{"key":"ref36","first-page":"261","article-title":"A comparative study of sexual dysfunction due to typical and atypical antipsychotics in remitted bipolar-I disorder","volume":"46","author":"Nagaraj","year":"2004","journal-title":"Indian J Psychiatry"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.eurpsy.2005.12.005","article-title":"Effects of atypical and typical antipsychotic treatments on sexual function in patients with schizophrenia: 12-month results from the Intercontinental Schizophrenia Outpatient Health Outcomes (IC-SOHO) study","volume":"21","author":"Dossenbach","year":"2006","journal-title":"Eur Psychiatry J Assoc Eur Psychiatr"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.schres.2006.04.005","article-title":"Sexual dysfunction associated with second-generation antipsychotics in outpatients with schizophrenia or schizoaffective disorder: an empirical evaluation of olanzapine, risperidone, and quetiapine","volume":"86","author":"Byerly","year":"2006","journal-title":"Schizophr Res"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"265","DOI":"10.4103\/0019-5545.58291","article-title":"A comparative study of sexual dysfunction involving risperidone, quetiapine, and olanzapine","volume":"51","author":"Nagaraj","year":"2009","journal-title":"Indian J Psychiatry"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"347","DOI":"10.11919\/j.issn.1002-0829.214101","article-title":"Sexual dysfunction in outpatients with schizophrenia in Turkey: a cross-sectional study","volume":"26","author":"Hocaoglu","year":"2014","journal-title":"Shanghai Arch Psychiatry"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1080\/0092623X.2018.1447055","article-title":"Sexual Dysfunction Among Patients With Schizophrenia in Southwest Nigeria","volume":"44","author":"Esan","year":"2018","journal-title":"J Sex Marital Ther"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.encep.2012.03.002","article-title":"Hyperprolactin\u00e9mies induites par les antipsychotiques: physiopathologie, clinique et surveillance [Antipsychotic-drug-induced hyperprolactinemia: physiopathology, clinical features and guidance]","volume":"40","author":"Besnard","year":"2014","journal-title":"Encephale"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1177\/0269881114562090","article-title":"\u201cFirst do no harm.\u201d A systematic review of the prevalence and management of antipsychotic adverse effects","volume":"29","author":"Young","year":"2015","journal-title":"J Psychopharmacol Oxf Engl"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1517\/14740338.2014.906579","article-title":"Second-generation and newly approved antipsychotics, serum prolactin levels and sexual dysfunctions: a critical literature review","volume":"13","author":"De Hert","year":"2014","journal-title":"Expert Opin Drug Saf"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.eurpsy.2007.01.001","article-title":"Sexual dysfunction in patients with schizophrenia on antipsychotic medication","volume":"22","author":"U\u00e7ok","year":"2007","journal-title":"Eur Psychiatry J Assoc Eur Psychiatr."},{"key":"ref46","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1080\/00224490802624414","article-title":"The impact of aging on human sexual activity and sexual desire","volume":"46","author":"Kontula","year":"2009","journal-title":"J Sex Res"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1037\/pag0000347","article-title":"Sexual activity, sexual thoughts, and intimacy among older adults: Links with physical health and psychosocial resources for successful aging","volume":"34","author":"Kolodziejczak","year":"2019","journal-title":"Psychol Aging"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1080\/00224490209552124","article-title":"Sexual dysfunction: overview of prevalence, etiological factors, and treatments","volume":"39","author":"Heiman","year":"2002","journal-title":"J Sex Res"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1016\/j.urology.2004.06.055","article-title":"Sexual behavior and sexual dysfunctions after age 40: the global study of sexual attitudes and behaviors","volume":"64","author":"Nicolosi","year":"2004","journal-title":"Urology"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1186\/s12888-019-2205-5","article-title":"Sexual dysfunction in Chinese rural patients with schizophrenia","volume":"19","author":"Huang","year":"2019","journal-title":"BMC Psychiatry"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1002\/hup.2489","article-title":"Factors associated with self-rated sexual function in Korean patients with schizophrenia receiving risperidone monotherapy","volume":"30","author":"Lee","year":"2015","journal-title":"Hum Psychopharmacol"},{"key":"ref52","first-page":"79","article-title":"Instruments for measuring quality of life in mental illnesses","volume-title":"Quality of Life in Mental Disorders","author":"Lehman","year":"1997"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15761\/JTBR.1000103","article-title":"Quality of life in psychiatric disorders","volume":"1","author":"Chaudhury","year":"2018","journal-title":"Trends Biomed Res"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1177\/2045125315596897","article-title":"Enhancing adherence, subjective well-being and quality of life in patients with schizophrenia: which role for long-acting risperidone?","volume":"5","author":"Niolu","year":"2015","journal-title":"Therap Adv Psychopharmacol"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1080\/0092623X.2011.606884","article-title":"Subjective quality of life and sexual dysfunction in outpatients with schizophrenia or schizoaffective disorder","volume":"39","author":"Bushong","year":"2013","journal-title":"J Sex Marital Ther"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.schres.2007.04.033","article-title":"Sexual functioning, psychopathology and quality of life in patients with schizophrenia","volume":"94","author":"Fan","year":"2007","journal-title":"Schizophr Res"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1176\/ajp.156.4.631","article-title":"Sexual disturbances during clozapine and haloperidol treatment for schizophrenia","volume":"156","author":"Hummer","year":"1999","journal-title":"Am J Psychiatry"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/s0920-9964(02)00350-x","article-title":"Evaluating sexual function in patients with treatment-resistant schizophrenia","volume":"63","author":"Kelly","year":"2003","journal-title":"Schizophr Res"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1002\/hup.1213","article-title":"The low frequency of reported sexual dysfunction in Asian patients with schizophrenia (2001-2009): low occurrence or ignored side effect?","volume":"26","author":"Xiang","year":"2011","journal-title":"Hum Psychopharmacol"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.psychres.2005.07.002","article-title":"Socio-demographic and clinical predictors of quality of life in patients with schizophrenia or schizo-affective disorder","volume":"137","author":"Caron","year":"2005","journal-title":"Psychiatry Res"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s10597-005-5077-8","article-title":"Predictors of quality of life in schizophrenia","volume":"41","author":"Caron","year":"2005","journal-title":"Community Ment Health J"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1023\/A:1018742513643","article-title":"Quality of life, gender and schizophrenia: a cross-national survey in Canada, Cuba, and U.S.A","volume":"34","author":"Vandiver","year":"1998","journal-title":"Community Ment Health J"},{"key":"ref63","first-page":"S60","article-title":"Predictors of psychological distress and quality of life in disadvantaged socio-economic populations of Montreal","volume":"79","author":"Caron","year":"2002","journal-title":"J. Urban Health"}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2023.1227218\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T07:13:55Z","timestamp":1693552435000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2023.1227218\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,1]]},"references-count":63,"alternative-id":["10.3389\/fpsyt.2023.1227218"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2023.1227218","relation":{},"ISSN":["1664-0640"],"issn-type":[{"type":"electronic","value":"1664-0640"}],"subject":[],"published":{"date-parts":[[2023,9,1]]},"article-number":"1227218"}}